Medical Mycology – Page 10

Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi

mycolabadmin

Fungal infections are becoming harder to treat as fungi develop resistance to antifungal drugs. This review explains how scientists can use experimental evolution—growing fungi in controlled laboratory conditions while exposing them to drugs—to understand how and why resistance develops. By studying these evolutionary processes and using mathematical models to predict outcomes, researchers can develop better treatment strategies, including combination therapies and drug cycling approaches to prevent resistance from emerging.

Brown locusts, Locustana pardalina, host fluconazole-resistant Candidozyma (Candida) auris, closely related to Clade III clinical strains

mycolabadmin

Researchers discovered that brown locusts in South Africa can carry a dangerous drug-resistant fungus called Candida auris in their digestive systems. This fungus, which causes serious infections in hospitals and is resistant to the antifungal drug fluconazole, may use locusts as a way to spread to humans or other environments. The study suggests that insects could play an important role in how dangerous fungi emerge and spread globally, particularly in warm climates where locusts thrive.

De Novo Genome Assembly and Comparative Genome Analysis of the Novel Human Fungal Pathogen Trichosporon austroamericanum Type-Strain CBS 17435

mycolabadmin

Scientists sequenced the complete genome of a dangerous fungal species called Trichosporon austroamericanum that can cause serious infections in humans, particularly transplant patients. Using advanced long-read sequencing technology, they assembled the organism’s 21 million base pair genome and compared it to a closely related fungal species. The analysis showed this species is genetically distinct and has interesting characteristics that help it survive at higher temperatures than most other fungi. This genetic information will help doctors and researchers better understand and treat infections caused by this emerging pathogenic yeast.

Cryptococcus albidus (Naganishia albida) meningitis in a young patient with T-cell acute lymphoblastic leukaemia

mycolabadmin

A 16-year-old boy with blood cancer (T-ALL) developed a brain infection caused by a rare fungus called Cryptococcus albidus. Doctors initially thought he had a viral infection caused by herpes, but tests on his spinal fluid revealed the true fungal culprit. He was treated with antifungal medications that led to his recovery, emphasizing the importance of thorough testing when immunocompromised patients develop serious infections.

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy

mycolabadmin

Fungal infections are a serious public health problem, but unlike cancer and AIDS, they lack strong patient advocacy movements to raise awareness and secure funding. This paper argues that patients with fungal diseases have important insights about their care needs that could help improve policies and research if their voices were heard. The authors propose establishing unified advocacy organizations, like the MyCARE Foundation, to bring patients, doctors, and policymakers together to better address this neglected health challenge.

Advances in Fungal Infection Research: From Novel Diagnostics to Innovative Therapeutics

mycolabadmin

This editorial discusses the growing challenge of fungal infections worldwide, which disproportionately affect people with weakened immune systems. New diagnostic tools using molecular testing can now quickly identify fungal infections, while researchers are developing novel treatments including repurposed drugs and immune-boosting therapies. The article emphasizes that coordinated efforts among doctors, scientists, and public health officials are essential to combat rising antifungal resistance and improve patient outcomes.

Genome characterization of Trichophyton mentagrophytes genotype VII strain PG12DES from Italy

mycolabadmin

Researchers in Italy studied a fungal strain that causes skin infections, particularly ringworm and related conditions. This strain is spreading globally and can potentially be transmitted through sexual contact. The study found that the Italian strain is closely related to another strain found in Moldova and is susceptible to currently used antifungal medications. Understanding this fungus at the genetic level helps doctors monitor its spread and identify if it develops resistance to treatments.

Immunometabolic reprogramming in macrophages infected with active and dormant Cryptococcus neoformans: differential modulation of respiration, glycolysis, and fatty acid utilization

mycolabadmin

This research examines how immune cells (macrophages) respond differently to active versus dormant forms of a dangerous fungus called Cryptococcus neoformans. The dormant form causes the immune cells to accumulate fatty acids differently than the active fungus, which may help the fungus establish long-term infections. Understanding these differences could lead to better treatments for cryptococcal infections, which are particularly dangerous for immunocompromised individuals.

Current taxonomic status of the cultivable and uncultivable Paracoccidioides species

mycolabadmin

Researchers have clarified the scientific names and classification of five species of fungus that cause disease in humans and dolphins. Some previously proposed species names were found to be invalid because they didn’t follow proper naming rules. The paper recommends that scientists use updated disease names like paracoccidiodomycosis instead of the older term lobomycosis to maintain consistency in medical terminology.

Occurrence of Pathogenic and Allergenic Molds in the Outdoor and Indoor Environment of a Major Hospital and Molecular Epidemiology of Aspergillus fumigatus in Kuwait

mycolabadmin

Researchers in Kuwait found many types of mold in and around a hospital, with some being resistant to common antifungal medications. They discovered that the same mold species were found both outdoors and in the hospital environment, suggesting patients could catch infections from the surrounding air. The study identified molds that could cause serious infections in vulnerable patients and found that about 10% of environmental samples contained drug-resistant strains that were also found in sick patients.

Research Topic: Medical Mycology